Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
G2V3
- Development stage
- Unknown
- Lead developer
- Centaur Pharmaceuticals
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
G2V3 is a multi-ingredient dietary supplement marketed by Centaur Pharmaceuticals. It is formulated as an oral capsule containing a combination of Panax ginseng extract, Ginkgo biloba, benfotiamine, quercetin, pyridoxal 5-phosphate, L-methylfolate, biotin, vitamin B12, and chromium picolinate. G2V3 is primarily used to support cognitive function, manage neurodegenerative disorders, and promote overall neurological health and vitality. The combination of vitamins, minerals, and botanical extracts provides antioxidant and neuroprotective benefits, helping to protect cells from oxidative stress and support healthy nerve function.
- Brand names
- G2V3G-2V3G 2V3
Beyond the preview
Go deeper on G2V3.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on G2V3.